BioMaxima S.A.
BMX.WA
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.93M
Close$
Share Statistics
| Market cap | $41.93 Million |
|---|---|
| Enterprise Value | $57.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.03 |
| Beta | 0.31 |
| Outstanding Shares | 4,193,118 |
Return
| Return on Equity | 1.67% |
|---|---|
| Return on Assets | 1.02% |
| Return on Invested Capital | 0.35% |
Valuation & Multiples
| P/E Ratio | 52.08 |
|---|---|
| PEG | -32.55 |
| Price to Sales | 0.72 |
| Price to Book Ratio | 0.84 |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | 270.79 |
| Enterprise Value to Net Income | 70 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
December 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$20.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioMaxima S.A.
143 employees
CEO: Lukasz Maria Urban BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehyd...